Skip to main content
Erschienen in: Infection 6/2010

01.12.2010 | Clinical and Epidemiological Study

Bacteraemic community-acquired pneumonia due to Gram-negative bacteria: incidence, clinical presentation and factors associated with severity during hospital stay

verfasst von: L. A. Ruiz, A. Gómez, C. Jaca, L. Martínez, B. Gómez, R. Zalacain

Erschienen in: Infection | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

Many studies have evaluated the clinical characteristics of Gram-negative bacteria (GNB) pneumonia. However, in most cases the bacteriological diagnosis is based on unreliable respiratory samples, and research rarely focuses on only bacteraemic patients. The aim of this study was to describe the incidence, clinical characteristics, outcomes, and factors associated with severity during the hospital stay of patients diagnosed with bacteraemic community-acquired pneumonia (CAP) due to GNB.

Materials and methods

Patients consecutively admitted with bacteraemic CAP due to GNB were enrolled in the study, with exclusion of additional foci of infection.

Results

CAP due to GNB accounted for 1.2% of the total CAP cases admitted and 3.5% of those with a confirmed aetiological diagnosis. Fifty-one patients were studied (mean age: 73 ± 11.3 years). Escherichia coli (30 cases; 58.8%) and Klebsiella pneumoniae (9 cases; 17.6%) were the most commonly isolated strains. The main symptoms were fever, cough, and dyspnoea. Eleven (21.6%) patients presented mental confusion, ten (19.6%) followed a severe clinical course, and six (11.8%) died. Absence of fever, radiologically multilobar involvement, and the prescription of an inadequate empirical antimicrobial therapy were independent factors associated with severity during the hospital stay.

Conclusion

Bacteraemic CAP due to GNB is an uncommon entity. Among the patients studied, E. coli was the main GNB found. A total of 19.6% of patients followed a severe clinical course. The factors identified in this study may alert physicians to a group of patients at risk of suffering complications during their hospital stay.
Literatur
1.
Zurück zum Zitat Koulenti D, Rello J. Gram-negative bacterial pneumonia: aetiology and management. Curr Opin Pulm Med. 2006;12:198–204.PubMed Koulenti D, Rello J. Gram-negative bacterial pneumonia: aetiology and management. Curr Opin Pulm Med. 2006;12:198–204.PubMed
2.
Zurück zum Zitat Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivete SL, Briggs JP, Lamm W, Clark C, MacFarquhar J, Walton AL, Reller LB, Sexton DJ. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002;137:791–9.PubMed Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivete SL, Briggs JP, Lamm W, Clark C, MacFarquhar J, Walton AL, Reller LB, Sexton DJ. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002;137:791–9.PubMed
3.
Zurück zum Zitat Falguera M, Carratala J, Ruiz-Gonzalez A, García-Vidal C, Gazquez I, Dorca J, Gudiol F, Porcel JM. Risk factors and outcome of community acquired pneumonia due to Gram-negative bacilli. Respirology. 2009;14:105–11.CrossRefPubMed Falguera M, Carratala J, Ruiz-Gonzalez A, García-Vidal C, Gazquez I, Dorca J, Gudiol F, Porcel JM. Risk factors and outcome of community acquired pneumonia due to Gram-negative bacilli. Respirology. 2009;14:105–11.CrossRefPubMed
4.
Zurück zum Zitat Arancibia F, Bauer T, Ewig S, Mensa J, Gonzalez J, Niederman MS, Torres A. Community acquired pneumonia due to gram negative bacteria and Pseudomonas aeruginosa. Arch Intern Med. 2002;162:1849–58.CrossRefPubMed Arancibia F, Bauer T, Ewig S, Mensa J, Gonzalez J, Niederman MS, Torres A. Community acquired pneumonia due to gram negative bacteria and Pseudomonas aeruginosa. Arch Intern Med. 2002;162:1849–58.CrossRefPubMed
5.
Zurück zum Zitat Kang CI, Song JH, Oh WS, Ko KS, Chung DR, Peck KR. Clinical outcomes and risk factors of community acquired pneumonia caused by gram negative bacilli. Eur J Clin Microbiol Infect Dis. 2008;27:657–61.CrossRefPubMed Kang CI, Song JH, Oh WS, Ko KS, Chung DR, Peck KR. Clinical outcomes and risk factors of community acquired pneumonia caused by gram negative bacilli. Eur J Clin Microbiol Infect Dis. 2008;27:657–61.CrossRefPubMed
6.
Zurück zum Zitat Bartlett JG, Breiman RF, Mandell LA, File TM, The Infectious Disease Society of America. Community-acquired pneumonia in adults: guidelines for management. Clin Infect Dis. 1998;26:811–38.CrossRefPubMed Bartlett JG, Breiman RF, Mandell LA, File TM, The Infectious Disease Society of America. Community-acquired pneumonia in adults: guidelines for management. Clin Infect Dis. 1998;26:811–38.CrossRefPubMed
7.
Zurück zum Zitat American Thoracic Society. Guidelines for the management of adults with community acquired pneumonia. Am J Respir Crit Care Med. 2001;163:1730–54. American Thoracic Society. Guidelines for the management of adults with community acquired pneumonia. Am J Respir Crit Care Med. 2001;163:1730–54.
8.
Zurück zum Zitat Metersky ML, Ma A, Bratzier DW, Houck PM. Predicting bacteraemia in patients with community acquired pneumonia. Am J Respir Crit Care Med. 2004;169:342–7.CrossRefPubMed Metersky ML, Ma A, Bratzier DW, Houck PM. Predicting bacteraemia in patients with community acquired pneumonia. Am J Respir Crit Care Med. 2004;169:342–7.CrossRefPubMed
9.
Zurück zum Zitat Falguera M, Trujillano J, Caro S, Menéndez R, Carratalá J, Ruiz-González A, Vilà M, García M, Porcel JM, Torres A, NAC-CALIDAD (Proyecto Integrado de Investigación de la Sociedad Española de Patología del Aparato Respiratorio sobre Infecciones Respiratorias de Vías Bajas) Study Group. A prediction rule for estimating the risk of bacteremia in patients with community-acquired pneumonia. Clin Infect Dis 2009; 49:409–16. Falguera M, Trujillano J, Caro S, Menéndez R, Carratalá J, Ruiz-González A, Vilà M, García M, Porcel JM, Torres A, NAC-CALIDAD (Proyecto Integrado de Investigación de la Sociedad Española de Patología del Aparato Respiratorio sobre Infecciones Respiratorias de Vías Bajas) Study Group. A prediction rule for estimating the risk of bacteremia in patients with community-acquired pneumonia. Clin Infect Dis 2009; 49:409–16.
10.
Zurück zum Zitat Marrie TJ, Durant H, Yates L. Community acquired pneumonia requiring hospitalization: 5 year prospective study. Rev Infect Dis. 1989;2:586–99. Marrie TJ, Durant H, Yates L. Community acquired pneumonia requiring hospitalization: 5 year prospective study. Rev Infect Dis. 1989;2:586–99.
11.
Zurück zum Zitat Alfageme I, Aspa J, Bello S, Blanquer J, Blanquer R, Borderías L, Bravo C, de Celis R, de Gracia X, Dorca J, Gallardo J, Gallego M, Menéndez R, Molinos L, Paredes C, Rajas O, Rello J, Rodríguez de Castro F, Roig J, Sánchez-Gascón F, Torres A, Zalacain R, Grupo de Estudio de la Neumonía Adquirida en la Comunidad. Area de Tuberculosis e Infecciones Respiratorias (TIR)-SEPAR: Normativas para el diagnóstico y tratamiento de la neumonía adquirida en la comunidad (Sociedad Española de Neumología y Cirugía Torácica). Arch Bronconeumol 2005; 41:272–89. Alfageme I, Aspa J, Bello S, Blanquer J, Blanquer R, Borderías L, Bravo C, de Celis R, de Gracia X, Dorca J, Gallardo J, Gallego M, Menéndez R, Molinos L, Paredes C, Rajas O, Rello J, Rodríguez de Castro F, Roig J, Sánchez-Gascón F, Torres A, Zalacain R, Grupo de Estudio de la Neumonía Adquirida en la Comunidad. Area de Tuberculosis e Infecciones Respiratorias (TIR)-SEPAR: Normativas para el diagnóstico y tratamiento de la neumonía adquirida en la comunidad (Sociedad Española de Neumología y Cirugía Torácica). Arch Bronconeumol 2005; 41:272–89.
12.
Zurück zum Zitat Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, Coley CM, Marrie TJ, Kapoon WN. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336:243–50.CrossRefPubMed Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, Coley CM, Marrie TJ, Kapoon WN. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336:243–50.CrossRefPubMed
13.
Zurück zum Zitat Dorca J, Bello S, Blanquer J, de Celis R, Molinos L, Torres A, Verano A, Zalacain R. Diagnóstico y tratamiento de la neumonía adquirida en la comunidad. Arch Bronconeumol. 1997;33:240–6.PubMed Dorca J, Bello S, Blanquer J, de Celis R, Molinos L, Torres A, Verano A, Zalacain R. Diagnóstico y tratamiento de la neumonía adquirida en la comunidad. Arch Bronconeumol. 1997;33:240–6.PubMed
14.
Zurück zum Zitat España PP, Capelastegui A, Gorordo I, Esteban C, Oribe M, Ortega M, Bilbao A, Quintana JM. Development and validation of a clinical prediction rule for severe community acquired pneumonia. Am J Respir Crit Care Med. 2006;174:1249–56.CrossRefPubMed España PP, Capelastegui A, Gorordo I, Esteban C, Oribe M, Ortega M, Bilbao A, Quintana JM. Development and validation of a clinical prediction rule for severe community acquired pneumonia. Am J Respir Crit Care Med. 2006;174:1249–56.CrossRefPubMed
15.
Zurück zum Zitat Levy MM, Fink M, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G, SCCM/ESICM/ACCP/ATS/SIS. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31:1250–6. Levy MM, Fink M, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G, SCCM/ESICM/ACCP/ATS/SIS. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31:1250–6.
16.
Zurück zum Zitat Ko WC, Paterson D, Sagnimeni A, Hansen D, Von Gotteborg A, Mohapatra S, Casellas JM, Goossens H, Mulazimoglu L, Trenholme G, Klugman KP, McCormack JG, Yu VL. Community acquired Klebsiella pneumoniae bacteremia: global differences in clinical patterns. Emerg Infect Dis. 2002;8:160–6.CrossRefPubMed Ko WC, Paterson D, Sagnimeni A, Hansen D, Von Gotteborg A, Mohapatra S, Casellas JM, Goossens H, Mulazimoglu L, Trenholme G, Klugman KP, McCormack JG, Yu VL. Community acquired Klebsiella pneumoniae bacteremia: global differences in clinical patterns. Emerg Infect Dis. 2002;8:160–6.CrossRefPubMed
17.
Zurück zum Zitat Leung WS, Chu CM, Tsang KY, Lo FH, Lo KF, Ho PL. Fulminant community-acquired Acinetobacter baumannii pneumonia as a distinct clinical syndrome. Chest. 2006;129:102–9.CrossRefPubMed Leung WS, Chu CM, Tsang KY, Lo FH, Lo KF, Ho PL. Fulminant community-acquired Acinetobacter baumannii pneumonia as a distinct clinical syndrome. Chest. 2006;129:102–9.CrossRefPubMed
18.
Zurück zum Zitat García Paez JI, Tengan FM, Barone AA, Levin AS, Costa SF. Factors associated with mortality in patients with bloodstream infection and pneumonia due to Stenotrophomonas maltophilia. Eur J Clin Microbiol Infect Dis. 2008;27:901–6.CrossRef García Paez JI, Tengan FM, Barone AA, Levin AS, Costa SF. Factors associated with mortality in patients with bloodstream infection and pneumonia due to Stenotrophomonas maltophilia. Eur J Clin Microbiol Infect Dis. 2008;27:901–6.CrossRef
19.
Zurück zum Zitat Allen MB, Prowse K. Bacteraemic Haemophilus influenzae pneumonia. Eur Respir J. 1988;1:929–31.PubMed Allen MB, Prowse K. Bacteraemic Haemophilus influenzae pneumonia. Eur Respir J. 1988;1:929–31.PubMed
20.
Zurück zum Zitat Buising KL, Thursky KA, Black JF, MacGregor L, Street AC, Kennedy MP, Brown GV. A prospective comparison of severity scores for identifying patients with severe community acquired pneumonia: reconsidering what is meant by severe pneumonia. Thorax. 2006;6:419–24.CrossRef Buising KL, Thursky KA, Black JF, MacGregor L, Street AC, Kennedy MP, Brown GV. A prospective comparison of severity scores for identifying patients with severe community acquired pneumonia: reconsidering what is meant by severe pneumonia. Thorax. 2006;6:419–24.CrossRef
21.
Zurück zum Zitat Menéndez R, Torres A, Zalacain R, Aspa J, Martín-Villasclaras JJ, Borderías L, Benítez Moya JM, Ruiz-Manzano J, Blanquer J, Pérez D, Puzo C, Sánchez-Gascón F, Gallardo J, Alvarez CJ, Molinos L, Neumofail Group. Risk factors to treatment failure in community acquired pneumonia: implications for disease outcome. Thorax. 2004;59:960–5.CrossRefPubMed Menéndez R, Torres A, Zalacain R, Aspa J, Martín-Villasclaras JJ, Borderías L, Benítez Moya JM, Ruiz-Manzano J, Blanquer J, Pérez D, Puzo C, Sánchez-Gascón F, Gallardo J, Alvarez CJ, Molinos L, Neumofail Group. Risk factors to treatment failure in community acquired pneumonia: implications for disease outcome. Thorax. 2004;59:960–5.CrossRefPubMed
22.
Zurück zum Zitat Charles P, Wolf R, Whitby M, Fine MJ, Fuller AJ, Stirling R, Wright AA, Ramirez JA, Christiansen KJ, Waterer GW, Pierce RJ, Armstrong JG, Korman TM, Holmes P, Obrosky DS, Peyrani P, Johnson B, Hooy M, Australian Community-Acquired Pneumonia Study Collaboration, Grayson ML. SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Clin Infect Dis 2008; 47:375–84. Charles P, Wolf R, Whitby M, Fine MJ, Fuller AJ, Stirling R, Wright AA, Ramirez JA, Christiansen KJ, Waterer GW, Pierce RJ, Armstrong JG, Korman TM, Holmes P, Obrosky DS, Peyrani P, Johnson B, Hooy M, Australian Community-Acquired Pneumonia Study Collaboration, Grayson ML. SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Clin Infect Dis 2008; 47:375–84.
23.
Zurück zum Zitat Kang CL, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, Oh MD, Choe KW. Bloodstream infections caused by antibiotic-resistant gram negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother. 2005;49:760–6.CrossRefPubMed Kang CL, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, Oh MD, Choe KW. Bloodstream infections caused by antibiotic-resistant gram negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother. 2005;49:760–6.CrossRefPubMed
24.
Zurück zum Zitat Siegman-Igra Y, Ravona R, Primerman H, Giladi M. Pseudomonas aeruginosa bacteremia: an analysis of 123 episodes with particular emphasis on the effect of antibiotic therapy. Int J Infect Dis. 1998;2:211–5.CrossRefPubMed Siegman-Igra Y, Ravona R, Primerman H, Giladi M. Pseudomonas aeruginosa bacteremia: an analysis of 123 episodes with particular emphasis on the effect of antibiotic therapy. Int J Infect Dis. 1998;2:211–5.CrossRefPubMed
25.
Zurück zum Zitat Osih RB, McGregor JC, Rich SE, Moore AC, Furuno JP, Perencevich EN, Harris AD. Impact of empirical antibiotic therapy on outcomes in patients with Pseudomonas aeruginosa bacteremia. Antimicrob Agents Chemother. 2007;51:839–44.CrossRefPubMed Osih RB, McGregor JC, Rich SE, Moore AC, Furuno JP, Perencevich EN, Harris AD. Impact of empirical antibiotic therapy on outcomes in patients with Pseudomonas aeruginosa bacteremia. Antimicrob Agents Chemother. 2007;51:839–44.CrossRefPubMed
26.
Zurück zum Zitat Menéndez R, Torres A, Zalacain R, Aspa J, Martín J, Borderías L, Benítez-Moya JM, Ruiz-Manzano J, de Castro FR, Blanquer J, Pérez D, Puzo C, Sánchez-Gascón F, Gallardo J, Alvarez C, Molinos L, NEUMOFAIL Group. Guidelines for the treatment of community-acquired pneumonia: predictors of adherence and outcome. Am J Respir Crit Care Med. 2005;172:757–62.CrossRefPubMed Menéndez R, Torres A, Zalacain R, Aspa J, Martín J, Borderías L, Benítez-Moya JM, Ruiz-Manzano J, de Castro FR, Blanquer J, Pérez D, Puzo C, Sánchez-Gascón F, Gallardo J, Alvarez C, Molinos L, NEUMOFAIL Group. Guidelines for the treatment of community-acquired pneumonia: predictors of adherence and outcome. Am J Respir Crit Care Med. 2005;172:757–62.CrossRefPubMed
Metadaten
Titel
Bacteraemic community-acquired pneumonia due to Gram-negative bacteria: incidence, clinical presentation and factors associated with severity during hospital stay
verfasst von
L. A. Ruiz
A. Gómez
C. Jaca
L. Martínez
B. Gómez
R. Zalacain
Publikationsdatum
01.12.2010
Verlag
Urban and Vogel
Erschienen in
Infection / Ausgabe 6/2010
Print ISSN: 0300-8126
Elektronische ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-010-0058-4

Weitere Artikel der Ausgabe 6/2010

Infection 6/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.